⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
INDGN - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 3.4
| Stock Code | INDGN | Market Cap | 10,874 Cr. | Current Price | 453 ₹ | High / Low | 633 ₹ |
| Stock P/E | 56.0 | Book Value | 81.6 ₹ | Dividend Yield | 0.44 % | ROCE | 16.6 % |
| ROE | 12.6 % | Face Value | 2.00 ₹ | DMA 50 | 479 ₹ | DMA 200 | 525 ₹ |
| Chg in FII Hold | 0.18 % | Chg in DII Hold | 1.11 % | PAT Qtr | 34.8 Cr. | PAT Prev Qtr | 59.9 Cr. |
| RSI | 43.5 | MACD | -13.2 | Volume | 4,58,723 | Avg Vol 1Wk | 10,03,472 |
| Low price | 423 ₹ | High price | 633 ₹ | PEG Ratio | 5.38 | Debt to equity | 0.03 |
| 52w Index | 14.2 % | Qtr Profit Var | -30.3 % | EPS | 8.08 ₹ | Industry PE | 52.3 |
📊 Financial Overview
- Revenue & Profitability: PAT declined from ₹59.9 Cr. to ₹34.8 Cr. (QoQ), showing earnings pressure.
- Margins: ROE at 12.6% and ROCE at 16.6% are decent, reflecting moderate profitability and efficiency.
- Debt: Debt-to-equity ratio of 0.03 indicates a nearly debt-free balance sheet, which is a positive.
- Cash Flow: EPS of ₹8.08 is modest, limiting earnings strength relative to valuation.
💹 Valuation Metrics
- P/E Ratio: 56.0 vs Industry PE of 52.3 → slightly overvalued compared to peers.
- P/B Ratio: Price ₹453 vs Book Value ₹81.6 → trading at a steep premium.
- PEG Ratio: 5.38 → suggests valuation is expensive relative to growth.
- Intrinsic Value: Current valuation looks stretched; fundamentals do not fully justify premium multiples.
🏢 Business Model & Competitive Advantage
- Indo-German (INDGN) operates in specialty chemicals and industrial solutions.
- Competitive advantage lies in niche expertise and strong demand in industrial applications, but earnings volatility reduces resilience.
📈 Entry Zone & Long-Term Guidance
- Entry Zone: ₹420–450 range looks safer given valuation and technical weakness.
- Long-Term Holding: Suitable for investors seeking exposure to specialty chemicals, but monitor profitability consistency and valuation risks.
✅ Positive
- Debt-free balance sheet (Debt-to-equity 0.03).
- Decent ROE (12.6%) and ROCE (16.6%).
- Institutional confidence with FII (+0.18%) and DII (+1.11%) inflows.
⚠️ Limitation
- High P/E ratio (56.0) compared to industry average.
- PEG ratio (5.38) suggests valuation is expensive relative to growth.
- EPS of ₹8.08 is modest relative to price.
📉 Company Negative News
- Quarterly PAT dropped significantly (₹59.9 Cr. to ₹34.8 Cr.).
- Stock trading below DMA 50 & DMA 200, indicating bearish momentum.
📈 Company Positive News
- DII holdings increased (+1.11%), showing domestic institutional support.
- FII holdings also rose slightly (+0.18%).
🏦 Industry
- Industry PE at 52.3 highlights sector trades at slightly lower multiples than INDGN.
- Specialty chemicals sector growth supported by industrial demand and export opportunities.
🔎 Conclusion
- INDGN shows decent ROE/ROCE and debt-free status but faces earnings volatility and stretched valuation.
- Entry around ₹420–450 is safer for long-term investors.
- Hold for exposure to specialty chemicals, but monitor profitability consistency and valuation risks closely.